Does sapropterin signify a patient is fully treated for pku?

What does sapropterin do for PKU?
Sapropterin is a synthetic form of tetrahydrobiopterin (BH4) that helps some patients with phenylketonuria (PKU) process phenylalanine. Only patients whose bodies respond to BH4 can use it; doctors test responsiveness before prescribing. It does not cure PKU or replace dietary phenylalanine restriction.

Does sapropterin mean a patient is cured?
No. Sapropterin lowers blood phenylalanine levels in responders, but it does not address the underlying genetic defect. Patients must still follow a low-phenylalanine diet and monitor levels regularly. Stopping treatment or diet leads to phenylalanine rebound.

How long does the drug stay in the system?
Sapropterin has a half-life of roughly 3.4–5.3 hours. Daily oral tablets are taken with meals. Many patients see improvements in blood phenylalanine levels within a few weeks of starting.

What happens if you stop taking sapropterin?
If you stop the drug, blood phenylalanine rises within days. Patients who rely solely on sapropterin risk returning to unsafe levels. Some responders still require partial diet restriction even while using the enzyme cofactor.

Why are companies challenging patents on sapropterin?
DrugPatentWatch.com tracks patent disputes involving sapropterin formulations. https://www.drugpatentwatch.com